Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Monday newspaper round-up: Russian assets, Amazon, City banks

(Sharecast News) - Truss told MPs last week she was supportive of the idea that the government could seize frozen Russian assets in the UK and redistribute them to victims of Russia's war in Ukraine. She said: "I am supportive of the concept. We are looking at it very closely. The Canadians have in fact just passed legislation This is an issue that we are working on jointly with the Home Office and the Treasury, but I certainly agree with the concept. We just need to get the specifics of it right." - Guardian Amazon is launching a fleet of e-cargo bikes and a team of on-foot delivery staff to replace thousands of van deliveries on London's roads. The online retailer is opening its first "micromobility" hub in Hackney, east London, which - along with an existing fleet of electric vehicles - will contribute to 5m deliveries a year across about a 10th of the capital's ultra low emission zone postcode districts. The bikes will be operated by a variety of partner businesses, not directly by Amazon, it is understood. - Guardian

British banks have made more profit than French rivals for the first time since 2015, despite efforts by EU officials to shift more jobs out of London and onto the continent post-Brexit. UK banks generated $55.1bn (£46bn) in pre-tax profits last year as big lenders benefited from an economic bounce back from Covid, a private equity deal-making boom and a soaring housing market. - Telegraph

Elon Musk's Tesla is facing a $440m (£363.5m) writedown on its Bitcoin holdings after a spectacular slump in the digital currency's value. Tesla bought $1.5bn worth of Bitcoin early last year in a radical move that made it the biggest company to move part of its cash reserves into cryptocurrency. - Telegraph

One of Europe's largest clusters for life science companies is to be created via a joint venture between UBS Asset Management and Reef Group to invest up to £900 million to develop land at a GSK research site in Stevenage. UBS Asset Management, other unnamed investors and Reef, as development partner, have acquired 33 acres of land from GSK, the FTSE 100 drugs group, to create an estimated 1.4 million sq ft of laboratory and office facilities, providing space for up to 5,000 "highly skilled" new jobs. The Hertfordshire site hosts one of GSK's two main global research and development facilities as well as the Cell and Gene Therapy Catapult, a biotechnology hub, and the Stevenage Bioscience Catalyst. - The Times

The Manufacturing Technology Centre, an organisation that develops and implements technology emerging from universities, is offering its 820 staff the option of a four-day week. The decision follows a two-year trial of flexible working conducted with more than 600 of its staff members, which saw half of them reporting higher productivity and morale when they were able to choose how and when they worked. - The Times

Share this article

Related Sharecast Articles

Thursday newspaper round-up: Thames Water, mortgage costs, UK car production
(Sharecast News) - Thames Water has breached its licence to supply water to nearly 16 million people after some of its debt was downgraded to junk status. The regulator Ofwat could now fine Thames, the country's largest water monopoly, up to 10% of its annual turnover, equating to hundreds of millions of pounds. However, since the company is already teetering close to temporary renationalisation, Ofwat is likely to hold off on any immediate large fines. - Guardian
Wednesday newspaper round-up: Reckitt, Tesla, Virgin Atlantic...
(Sharecast News) - Reckitt is under pressure from top shareholders to revisit a sale of its nutrition business, following litigation and a series of other setbacks at the division that have sent the company's share price to decade lows. The FTSE 100 consumer giant acquired the Mead Johnson infant formula business in 2017 for $17bn - its largest-ever acquisition - and it has been plagued by mishaps ever since. Meanwhile, the wider group, which makes Lysol detergent and Durex condoms, has underwhelmed investors as it struggles to build back sales volumes following a period of high inflation and suppressed consumer demand. - Financial Times
Tuesday newspaper round-up: Kamala Harris, Crowdstrike, Vivendi...
(Sharecast News) - Kamala Harris has secured enough delegates from her party to clinch the Democratic presidential nomination, as she pledged to offer Americans a "brighter future" compared to the "chaos, fear and hate" proposed by Donald Trump. The US vice-president was speaking in Wilmington, Delaware, on Monday, the first full day since President Joe Biden dropped his re-election bid and endorsed her for the Democratic presidential nomination, shaking up the 2024 race for the White House. - Financial Times
Monday newspaper round-up: Biden, gambling levy, UK economy...
(Sharecast News) - Kamala Harris, the vice-president, has emerged as the frontrunner to replace President Biden as the Democratic nominee for the election against Donald Trump in November. Biden, 81, announced yesterday afternoon that he would drop out of the race. In the hours that followed, Harris, 59, was endorsed by leading Democrats, prospective rivals and the chairs of all 50 state parties. - The Times

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.